PRF1 and malignant colon neoplasm: In particular, we confirmed that the prevailing killing mechanism of iNKT cells was based on the presence of functional perforin and granzymes, as treatment with concanamycin A and DCI significantly impaired iNKT cell killing against the colon cancer lines tested.